For the Inventor, By the Inventor

Enter assignee name

Osaka Bioscience Institute

USPTO Granted Patents = 19

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 73

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

Shigekazu Nagata (10 out of 23 patents)

Yoshihiro Urade (5 out of 16 patents)

Norio Nakamura (4 out of 43 patents)

4. Naomi Eguchi (4 out of 6 patents)

5. Takashi Suda (3 out of 5 patents)

6. Naoto Itoh (3 out of 3 patents)

7. Shin Yonehara (3 out of 3 patents)

8. Tomohiro Takahashi (2 out of 60 patents)

9. Maximiliano Vasquez (2 out of 68 patents)

10. Kamon Shirakawa (2 out of 24 patents)

11. Yasuyoshi Watanabe (2 out of 21 patents)

12. Hiroshi Oda (2 out of 23 patents)

13. Nobuyuki Sato (2 out of 14 patents)

14. Kosuke Aritake (2 out of 3 patents)

15. Tomokazu Matsusue (2 out of 5 patents)

19 patents: Sort by Forward Citations

1. 8658390 - Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases (2014-02-25),

2. 7760925 - Method for automatically detecting degenerated regions in stained thin section slides (2010-07-20),

3. 7622554 - FAS ligand derived polypeptides (2009-11-24),

4. 7399596 - Method for predicting pregnancy-induced hypertension (2008-07-15),

5. 7314727 - Methods to facilitate diagnosis of normal pressure hydrocephalus (2008-01-01),

6. 7238718 - Method for treating myolytic disease and method for screening antimyolytic agent (2007-07-03),

7. 7202394 - Animal with the mass expression of human gene and test method by using the animal (2007-04-10),

8. 7128905 - Method of treating graft versus host disease by administration of a Fas antagonist (2006-10-31),

9. 6953847 - Fas antigen derivative (2005-10-11),

10. 6949360 - DNA coding for human cell surface antigen (2005-09-27),

11. 6905815 - Method of screening for inhibitors of VCP binding to polyglutamine, abeta, alpha-synuclein, and sod1 (2005-06-14),

12. 6897295 - Antibodies and fragments thereof to Fas ligand and Fas ligand derived polypeptides (2005-05-24),

13. 6884819 - Neuropathy remedies (2005-04-26),

14. 6270998 - DNA coding for human cell surface antigen (2001-08-07),

15. 6114507 - Anti-Fas ligand antibody and assay method using the anti-Fas ligand (2000-09-05),

Osaka Bioscience Institute (OBI) is a leading research institute in Japan dedicated to advancing scientific knowledge and driving innovation in the field of bioscience. Founded in 1971, OBI conducts cutting-edge research in various areas, including biomedicine, genetics, neuroscience, and plant science. Through collaboration with national and international partners, OBI aims to contribute to the development of new therapies, diagnostic tools, and technologies that can improve human health and well-being. Visit our website to learn more about our research, facilities, and contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#288 in Osaka

#2,975 in Japan

#31,712 in the World

Osaka Bioscience Institute

Forward Citations = 73

52 inventors:

Shigekazu Nagata (10 out of 23 patents)

Yoshihiro Urade (5 out of 16 patents)

Norio Nakamura (4 out of 43 patents)

4. Naomi Eguchi (4 out of 6 patents)

5. Takashi Suda (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…